Sixty waterborne disease outbreaks associated with splash pads were reported during 1997 to 2022, according to research published in the Dec. 5 issue of the U.S ...
Yesintek, formerly known as Bmab 1200, is a human interleukin-12 and -23 antagonist. The FDA has approved Yesintek (Ustekinumab-kfce), a biosimilar to Stelara (Ustekinumab), for the treatment of ...